The declining costs of gene editing and sequencing have made these technologies more commonplace in clinical practice.
The declining costs of gene editing and sequencing have made these technologies more commonplace in clinical practice. This has given rise to precision medicine, a strategy that empowers physicians to determine effective treatment and prevention strategies for specific groups. It also facilitates personalized treatment for a variety of diseases, including cancers.